Kathleen Moore to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Kathleen Moore has written about Antineoplastic Agents, Immunological.
Connection Strength
1.408
-
Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC). Gynecol Oncol. 2021 05; 161(2):382-388.
Score: 0.687
-
Management of the toxicities of common targeted therapeutics for gynecologic cancers. Gynecol Oncol. 2018 03; 148(3):591-600.
Score: 0.554
-
PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer. Gynecol Oncol. 2020 11; 159(2):322-328.
Score: 0.166